Financials
- Market Capitalization 3.66 B
- Employee 192
- Founded 2015
- CEO N/A
- Website www.relaytx.com
- Headquarter Delaware, United States
- FIGI BBG00DSS08K9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.38
ratio cours/chiffre d'affaires
161.99
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1534 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.49 USD | +0.03% | +0.06% | +0.41% | +48.47% | 3.85 B USD | ||
| 1554 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.02 USD | +0.46% | -4.09% | +14.20% | +74.64% | 3.73 B USD | ||
| 1576 | GPCR Structure Therapeutics Inc - American Depositary Shares | 50.59 USD | -2.03% | -10.21% | +18.45% | +89.19% | 3.60 B USD | ||
| 1577 | DNLI Denali Therapeutics Inc. - Common Stock | 22.65 USD | -14.46% | -13.15% | +2.40% | +40.07% | 3.59 B USD |